Please login to the form below

Not currently logged in
Email:
Password:

Catalent promotes Sharon Johnson within new organisation

She will be its senior VP of global quality and regulatory affairs

edit-Catalent-Sharon-JohnsonCatalent Pharma Solutions has appointed Sharon Johnson as senior VP of global quality and regulatory of its new quality, product development and regulatory affairs organisation.

Johnson will oversee the function that includes over 1,500 scientists, quality professionals and regulatory affairs experts. 

Prior to her promotion, Johnson held the same role at Catalent since 2009, overseeing the roll out of the company's global quality management system to over 20 sites globally.

She has over 30 years of experience in the pharma industry, including API and multiple dosages forms, discovery and launch of NCEs and life cycle management. Prior to joining Catalent, Johnson served as VP of quality for GE Healthcare's medical diagnostic division.

Commenting on the new organisation, Johnson said: “The overall goal of the quality, product development and regulatory affairs organisation will be to drive excellence and reliability across all of the products that we make and deliver.

“Our customer promise is not only to provide a reliable supply of their current, on going products but to deliver new products with the same rigorous commitment to excellence.”

Catalent, which is a provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has recently formed its quality, product development and regulatory affairs organisation.

18th March 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics